Cytokines induce nitric oxide-mediated mtDNA damage and apoptosis in oligodendrocytes

被引:55
|
作者
Druzhyna, NM [1 ]
Musiyenko, SI [1 ]
Wilson, GL [1 ]
LeDoux, SP [1 ]
机构
[1] Univ S Alabama, Dept Cell Biol & Neurosci, Coll Med, Mobile, AL 36688 USA
关键词
D O I
10.1074/jbc.m411531200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO) that is produced by inducible NO synthase (iNOS) in glial cells is thought to contribute significantly to the pathogenesis of multiple sclerosis. Oligodendrocytes can be stimulated to express iNOS by inflammatory cytokines, which are known to accumulate in the multiple sclerotic brain. The potentially pathological levels of NO produced under these circumstances can target a wide spectrum of intracellular components. We hypothesized that one of the critical targets for damage that leads to disease is mtDNA. In this study, we found that cytokines, in particular a combination of tumor necrosis factor-alpha (50 ng/ml) and IFN gamma (25 ng/ml), cause elevated NO production in primary cultures of rat oligodendrocytes. Western blot analysis revealed a strong enhancement of iNOS expression 48 h after cytokine treatment. Within the same time period, NO-mediated mtDNA damage was shown by Southern blot analysis and by ligation-mediated PCR. Targeting the DNA repair enzyme human 8-oxoguanine DNA glycosylase (hOGG1) to the mitochondria of oligodendrocytes had a protective effect against this cytokine-mediated mtDNA damage. Moreover, it was shown that mitochondrial transport sequence hOGG1-transfected oligodendrocytes had fewer apoptotic cells compared with cells containing vector only following treatment with the cytokines. Subsequent experiments revealed that targeting hOGG1 to mitochondria reduces the activation of caspase-9, showing that this recombinant protein works to reduce apoptosis that is occurring through a mitochondria-based pathway.
引用
收藏
页码:21673 / 21679
页数:7
相关论文
共 50 条
  • [31] The role of copper in nitric oxide-mediated vasodilation
    Schuschke, Dale A.
    CELL BIOLOGY AND TOXICOLOGY, 2008, 24 (04) : 349 - 353
  • [32] Oxygen dependence of nitric oxide-mediated signaling
    Hickok, Jason R.
    Vasudevan, Divya
    Jablonski, Kate
    Thomas, Douglas D.
    REDOX BIOLOGY, 2013, 1 (01): : 203 - 209
  • [33] Angiostatin inhibits, nitric oxide-mediated dilation
    Koshida, R
    Pritchard, KA
    Chilian, WM
    FASEB JOURNAL, 2002, 16 (04): : A123 - A123
  • [34] Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics
    Bonavida, Benjamin
    Garban, Hermes
    REDOX BIOLOGY, 2015, 6 : 486 - 494
  • [35] Is estradiol cardioprotection a nitric oxide-mediated effect?
    Duncan, AC
    Petrie, JR
    Brosnan, MJ
    Devlin, AM
    Bass, RA
    Charnock-Jones, DS
    Connell, JMC
    Dominiczak, AF
    Lumsden, MA
    HUMAN REPRODUCTION, 2002, 17 (07) : 1918 - 1923
  • [36] Nitric oxide-mediated vasodilation in human bone
    Draghici, Adina E.
    Ely, Matthew R.
    Hamner, Jason W.
    Taylor, J. Andrew
    MICROCIRCULATION, 2024, 31 (02)
  • [37] Nitric oxide-mediated vasodilation in human pregnancy
    Williams, DJ
    Vallance, PJT
    Neild, GH
    Spencer, JAD
    Imms, FJ
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (02): : H748 - H752
  • [38] NITRIC OXIDE-MEDIATED VASCULAR HYPERRESPONSIVENESS TO ENDOTHELIN
    REDMOND, EM
    HODGES, R
    ZHANG, S
    CAHILL, PA
    SITZMANN, JV
    GASTROENTEROLOGY, 1995, 108 (04) : A1000 - A1000
  • [39] TRANSNITROSYLATION IN NITRIC OXIDE-MEDIATED PENILE ERECTION
    Musicki, B.
    Lagoda, G.
    Goetz, T.
    La Favor, J.
    Burnett, A.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (02): : E31 - E31
  • [40] Myeloperoxidase potentiates nitric oxide-mediated nitrosation
    Lakshmi, VM
    Nauseef, WM
    Zenser, TV
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (03) : 1746 - 1753